|

Fumetinib combined platinum-based double chemotherapy Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Peng Zhang1

Indications

  • eGFR1
  • NSCLC (Non-small Cell Lung Cancer)1
  • Locally Advanced Non-Small Cell Lung Cancer1
  • Radiotherapy1
  • Lung Cancer1

Other1 trial

Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.